Objectives: To estimate the prevalence of hepatitis C virus (HCV) sero
positivity and known risk factors for HCV infection in a group of preg
nant women. Design: Cross-sectional survey. Setting: Lyell McEwin Heal
th Service, Elizabeth, South Australia (a general public hospital with
an annual average of about 2000 deliveries). Subjects: 1537 consecuti
ve women who delivered at the Lyell McEwin Health Service from Februar
y 1995 to December 1995. Outcome measures: Presence of HCV antibodies;
and associations between HCV-antibody status and known risk factors.
Results: 17 women (1.1%) were HCV-seropositive. Risk factors significa
ntly more prevalent among HCV-seropositive patients were: a history of
injecting drug use, a past or present sexual partner who had injected
drugs, having a tattoo and having been incarcerated. The proportions
who had received a blood transfusion, had acquired a sexually transmit
ted disease or were positive for hepatitis B virus surface antigen wer
e not significantly different between seropositive and seronegative wo
men. Multivariate analysis showed that only injecting drug use remaine
d a strong independent predictor of HCV-seropositivity (odds ratio [OR
], 50.1; P < 0.001), while having a tattoo approached significance (OR
, 3.5; P = 0.07). Conclusion: As only 1.1% of this sample of women wer
e HCV-seropositive, screening of all pregnant women does not seem warr
anted. Testing on the basis of a history of risk factors, such as inje
cting drug use and having a tattoo, would detect undiagnosed HCV infec
tions more efficiently.